{"id":"https://openalex.org/W3018624008","doi":"https://doi.org/10.1097/mol.0000000000000680","title":"Apolipoprotein C-II: the re-emergence of a forgotten factor","display_name":"Apolipoprotein C-II: the re-emergence of a forgotten factor","alternate_titles":[],"publication_year":2020,"publication_date":"2020-04-23","ids":{"openalex":"https://openalex.org/W3018624008","doi":"https://doi.org/10.1097/mol.0000000000000680","mag":"3018624008","pmid":"https://pubmed.ncbi.nlm.nih.gov/32332429"},"language":"en","primary_location":{"id":"doi:10.1097/mol.0000000000000680","doi":"https://doi.org/10.1097/mol.0000000000000680","is_oa":false,"landing_page_url":"https://doi.org/10.1097/mol.0000000000000680","pdf_url":null,"source":{"id":"https://openalex.org/S203964698","display_name":"Current Opinion in Lipidology","issn_l":"0957-9672","issn":["0957-9672","1473-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Lipidology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3018624008"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017767239","display_name":"Anna T Wolska","orcid":"https://orcid.org/0000-0001-9479-0741","observed_orcids":["https://orcid.org/0000-0001-9479-0741"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210106489","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210106489"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Anna Wolska","raw_affiliation_strings":["Lipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210106489"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040295868","display_name":"Mart Reimund","orcid":"https://orcid.org/0000-0002-9280-5409","observed_orcids":["https://orcid.org/0000-0002-9280-5409"]},"institutions":[{"id":"https://openalex.org/I111112146","display_name":"Tallinn University of Technology","ror":"https://ror.org/0443cwa12","country_code":"EE","type":"education","lineage":["https://openalex.org/I111112146"]}],"countries":["EE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mart Reimund","raw_affiliation_strings":["Department of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, Estonia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, Estonia","institution_ids":["https://openalex.org/I111112146"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068951391","display_name":"Alan Thomas Remaley","orcid":"https://orcid.org/0000-0003-2473-5549","observed_orcids":["https://orcid.org/0000-0003-2473-5549"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210106489","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210106489"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alan T. Remaley","raw_affiliation_strings":["Lipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210106489"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5017767239"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210106489"],"apc_list":null,"apc_paid":null,"fwci":1.457,"has_fulltext":false,"cited_by_count":60,"citation_normalized_percentile":{"value":0.84001445,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"31","issue":"3","first_page":"147","last_page":"153"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11844","display_name":"Lipid metabolism and biosynthesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/apolipoprotein-c-ii","display_name":"apolipoprotein C-II","score":1.0},{"id":"https://openalex.org/keywords/lipoprotein-lipase-activation","display_name":"lipoprotein lipase activation","score":0.9399999976158142},{"id":"https://openalex.org/keywords/triglyceride-rich-lipoproteins","display_name":"triglyceride-rich lipoproteins","score":0.9210000038146973},{"id":"https://openalex.org/keywords/hypertriglyceridemia","display_name":"hypertriglyceridemia","score":0.9549999833106995},{"id":"https://openalex.org/keywords/triglyceride-metabolism","display_name":"triglyceride metabolism","score":0.7929999828338623},{"id":"https://openalex.org/keywords/atherosclerosis","display_name":"atherosclerosis","score":0.9679999947547913},{"id":"https://openalex.org/keywords/cardiovascular-disease-treatment","display_name":"cardiovascular disease treatment","score":0.6779999732971191}],"concepts":[{"id":"https://openalex.org/C94879076","wikidata":"https://www.wikidata.org/wiki/Q420014","display_name":"Lipoprotein lipase","level":3,"score":0.8073716759681702},{"id":"https://openalex.org/C2776919658","wikidata":"https://www.wikidata.org/wiki/Q1467339","display_name":"Hypertriglyceridemia","level":4,"score":0.7173352837562561},{"id":"https://openalex.org/C62746215","wikidata":"https://www.wikidata.org/wiki/Q14890615","display_name":"Apolipoprotein B","level":3,"score":0.6230980753898621},{"id":"https://openalex.org/C197957613","wikidata":"https://www.wikidata.org/wiki/Q407280","display_name":"Cofactor","level":3,"score":0.5187180638313293},{"id":"https://openalex.org/C4733338","wikidata":"https://www.wikidata.org/wiki/Q2792936","display_name":"Lipid metabolism","level":2,"score":0.5117928385734558},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.4403611421585083},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4208610951900482},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.40166765451431274},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.39415544271469116},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.36857858300209045},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3495858907699585},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.340518593788147},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.32067710161209106},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.22810646891593933},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.12277355790138245}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008071","descriptor_name":"Lipoprotein Lipase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D008074","descriptor_name":"Lipoproteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008075","descriptor_name":"Lipoproteins, HDL","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015228","descriptor_name":"Hypertriglyceridemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015228","descriptor_name":"Hypertriglyceridemia","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015228","descriptor_name":"Hypertriglyceridemia","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D053304","descriptor_name":"Apolipoprotein C-II","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D053305","descriptor_name":"Apolipoprotein C-III","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/mol.0000000000000680","doi":"https://doi.org/10.1097/mol.0000000000000680","is_oa":false,"landing_page_url":"https://doi.org/10.1097/mol.0000000000000680","pdf_url":null,"source":{"id":"https://openalex.org/S203964698","display_name":"Current Opinion in Lipidology","issn_l":"0957-9672","issn":["0957-9672","1473-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Lipidology","raw_type":"journal-article"},{"id":"pmid:32332429","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32332429","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in lipidology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":49,"referenced_works":["https://openalex.org/W1568476234","https://openalex.org/W1588608604","https://openalex.org/W1593548000","https://openalex.org/W1802190645","https://openalex.org/W1918267826","https://openalex.org/W1944135887","https://openalex.org/W1963552725","https://openalex.org/W1972054363","https://openalex.org/W1981956598","https://openalex.org/W1984259997","https://openalex.org/W1992292595","https://openalex.org/W2007718055","https://openalex.org/W2007718923","https://openalex.org/W2015836295","https://openalex.org/W2022332493","https://openalex.org/W2032456325","https://openalex.org/W2039978909","https://openalex.org/W2047042491","https://openalex.org/W2059895389","https://openalex.org/W2067802636","https://openalex.org/W2072054150","https://openalex.org/W2114808162","https://openalex.org/W2115816529","https://openalex.org/W2119368892","https://openalex.org/W2142850613","https://openalex.org/W2142970078","https://openalex.org/W2145473370","https://openalex.org/W2170210469","https://openalex.org/W2236633653","https://openalex.org/W2286999219","https://openalex.org/W2315899065","https://openalex.org/W2334579686","https://openalex.org/W2345841042","https://openalex.org/W2553163325","https://openalex.org/W2618984243","https://openalex.org/W2738009647","https://openalex.org/W2747264648","https://openalex.org/W2767128978","https://openalex.org/W2782318315","https://openalex.org/W2899669642","https://openalex.org/W2904688359","https://openalex.org/W2912008260","https://openalex.org/W2914525760","https://openalex.org/W2955013370","https://openalex.org/W2970232262","https://openalex.org/W3003722439","https://openalex.org/W3216297003","https://openalex.org/W6677793098","https://openalex.org/W6926272914"],"related_works":["https://openalex.org/W2007718923","https://openalex.org/W2970232262","https://openalex.org/W2587826332","https://openalex.org/W3197432431","https://openalex.org/W2767128978","https://openalex.org/W2236633653","https://openalex.org/W4251127561","https://openalex.org/W2624115333","https://openalex.org/W3094883366","https://openalex.org/W2015836295"],"abstract_inverted_index":{"PURPOSE":[0],"OF":[1],"REVIEW:":[2],"Apolipoprotein":[3],"C-II":[4],"(apoC-II)":[5],"is":[6,38,176],"a":[7,17,73,189],"critical":[8],"cofactor":[9],"for":[10,52,77,129,143,192],"the":[11,45,53,66,85,98,115,122,160,163],"activation":[12,144],"of":[13,44,55,61,68,87,101,117,145,155,162,166,171],"lipoprotein":[14],"lipase":[15],"(LPL),":[16],"plasma":[18],"enzyme":[19],"that":[20],"hydrolyzes":[21],"triglycerides":[22],"(TG)":[23],"on":[24],"TG-rich":[25],"lipoproteins":[26],"(TRL).":[27],"Although":[28],"apoC-II":[29,69,88,107,140,172,185],"was":[30],"first":[31,83],"discovered":[32],"nearly":[33],"50":[34],"years":[35],"ago,":[36],"there":[37],"renewed":[39],"interest":[40],"in":[41,92,173],"it":[42],"because":[43],"recent":[46,134,181],"efforts":[47,124,135,182],"to":[48,106,114,125,136,159,183],"develop":[49,126,184],"new":[50,75,127],"drugs":[51,128],"treatment":[54],"hypertriglyceridemia":[56],"(HTG).":[57],"The":[58,169],"main":[59],"topic":[60],"this":[62],"review":[63,97],"will":[64],"be":[65],"development":[67,116],"mimetic":[70,141,186],"peptides":[71,142,150,187],"as":[72,178,180],"possible":[74],"therapy":[76,191],"cardiovascular":[78],"disease.":[79],"RECENT":[80],"FINDINGS:":[81],"We":[82,95,119],"describe":[84,133],"biochemistry":[86],"and":[89,109,147],"its":[90],"role":[91,170],"TRL":[93],"metabolism.":[94],"then":[96],"clinical":[99],"findings":[100],"HTG,":[102],"particularly":[103],"those":[104],"related":[105,158],"deficiency,":[108],"how":[110,148],"TG":[111,174],"metabolism":[112,175],"relates":[113],"atherosclerosis.":[118],"next":[120],"summarize":[121],"current":[123],"HTG.":[130,193],"Finally,":[131],"we":[132],"make":[137],"small":[138],"synthetic":[139],"LPL":[146],"these":[149],"unexpectedly":[151],"have":[152],"other":[153],"mechanisms":[154],"action":[156],"mostly":[157],"antagonism":[161],"TG-raising":[164],"effects":[165],"apoC-III.":[167],"SUMMARY:":[168],"reviewed,":[177],"well":[179],"into":[188],"novel":[190]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3018624008","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":5}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2020-05-01T00:00:00"}
